A recent study on antibody therapy to human L1CAM in pancreatic carcinoma cells in a transgenic mouse model showed also a significant reduction of tumor size after treatment with the mAb L1-9.3/2a. The gene discussed is L1CAM; the disease is exocrine pancreatic carcinoma.